NFKB1 and central nervous system cancer: We further performed rescue assays and found that NF-kB inhibitors treatment effectively inhibited glioma proliferation, invasion, migration, MES transition, and other malignant behaviors [50], resulting in the disappearance of all promoting effects caused by PLOD1 overexpression.